The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Total Voting Rights

30 Nov 2020 07:00

RNS Number : 7942G
Dunelm Group plc
30 November 2020
 

Dunelm Group plc

30 November 2020

 

 

 

DUNELM GROUP plc

 

 Total Voting Rights

 

 

 

 

 

In conformity with R 5.6.1 of the Disclosure and Transparency Rules, the Company notifies the market that at the date of this announcement the Company's issued ordinary share capital comprises 202,833,931 ordinary shares with a nominal value of 1p each ("Ordinary Shares"), of which a total of 479,366 shares are held in treasury. Therefore, the total number of Ordinary Shares with voting rights in the Company is 202,354,565 Ordinary Shares.

 

The number of 202,354,565 Ordinary Shares above may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the ordinary share capital of the Company under the Disclosure and Transparency Rules.

 

 

 

Name of authorised Company official responsible for making this notification:

 

Dawn Durrant, Company Secretary

 

InvestorRelations@dunelm.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRLDLFLBFLEFBB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.